Applied Stock Story

AMTI -  USA Stock  

USD 14.84  1.25  7.77%

It seems as Applied Molecular may not have a good chance to recover from the current drop as its shares fell again. The firm current daily volatility is 3.26 percent, with a beta of 1.01 and an alpha of -0.82 over DOW. As many millenniums are trying to avoid the current volatility, we are going to concentrate on Applied Molecular Transport a little further to understand its historical price patterns. We will analyze why it could be a much better year for Applied Molecular shareholders.
Published over a month ago
View all stories for Applied Molecular | View All Stories
Should you keep an eye on Applied Molecular (NASDAQ:AMTI) management before November?
Applied Molecular Transport currently holds roughly 129.87 M in cash with (58.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.68.
One of the ways to look at asset utilization of Applied is to check how much profit was generated for every dollar of assets it reports. Applied Molecular Transport shows a negative utilization of assets of -46.64 percent, losing $0.47 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Applied Molecular Transport shows how discouraging it operates for each dollar spent on its assets.
Investing in Applied Molecular, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding Applied Molecular along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Applied Molecular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Applied Molecular in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Applied Molecular. Your research has to be compared to or analyzed against Applied Molecular's peers to derive any actionable benefits. When done correctly, Applied Molecular's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Applied Molecular.

How important is Applied Molecular's Liquidity

Applied Molecular financial leverage refers to using borrowed capital as a funding source to finance Applied Molecular Transport ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Applied Molecular financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Applied Molecular's total debt and its cash.

How Applied utilizes its cash?

To perform a cash flow analysis of Applied Molecular, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Applied Molecular is receiving and how much cash it distributes out in a given period. The Applied Molecular cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Applied Molecular Net Cash Flow from Operations is most likely to decrease significantly in the upcoming years. The last year's value of Net Cash Flow from Operations was reported at (58.89 Million)

Applied Molecular Correlation with Peers

Investors in Applied can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Applied Molecular Transport. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Applied Molecular and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Applied is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage.
Please check volatility of Applied for more details

Purchase by Epiq Capital Group Llc of 7135 shares of Applied Molecular

Legal trades by Applied Molecular insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Applied insider trading alert for perchase of common stock by Epiq Capital Group Llc, the corporate stakeholder, on 18th of November 2021. This event was filed by Applied Molecular Transpo with SEC on 2021-11-18. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Detailed Perspective On Applied Molecular

Applied Molecular secures Sharpe Ratio (or Efficiency) of -0.23, which signifies that the company had -0.23% of return per unit of risk over the last 3 months. Macroaxis standpoint towards foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Applied Molecular Transport exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Applied Molecular risk adjusted performance of (0.19), and Mean Deviation of 2.49 to double-check the risk estimate we provide.

Does Applied Molecular have anything more to lay out in October?

Current Skewness is up to 0.01. Price may drop again.
As of the 16th of October 2021, Applied Molecular shows the mean deviation of 2.49, and Risk Adjusted Performance of (0.19). Applied Molecular technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Applied Molecular Transport, which can be compared to its rivals. Please confirm Applied Molecular coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Applied Molecular is priced correctly, providing market reflects its regular price of 21.6 per share. Given that Applied Molecular has jensen alpha of (0.82), we suggest you to validate Applied Molecular Transport's prevailing market performance to make sure the company can sustain itself at a future point.

Our Conclusion on Applied Molecular

While some other companies in the biotechnology industry are either recovering or due for a correction, Applied may not be as strong as the others in terms of longer-term growth potentials. On the whole, as of the 16th of October 2021, our analysis shows that Applied Molecular almost mirrors the market. The company is undervalued and projects quite high odds of distress for the next 2 years. Our actual 90 days advice on the company is Cautious Hold.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Applied Molecular Transport. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to